A Federated Database for Obesity Research: An IMI-SOPHIA Study.
Autorzy:
Delfin C; Novo Nordisk A/S, 2860 Søborg, Denmark. Dragan I; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Kuznetsov D; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Tajes JF; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre (CRC), Lund University, Jan Waldenströmsgata 35, SE-20502 Malmö, Sweden. Smit F; Maastricht Center for Systems Biology, Faculty of Science and Engineering, Maastricht University, Paul Henri Spaaklaan 1, 6229 EN Maastricht, The Netherlands. Coral DE; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre (CRC), Lund University, Jan Waldenströmsgata 35, SE-20502 Malmö, Sweden. Farzaneh A; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands. Haugg A; Global Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany. Hungele A; Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, 89081 Ulm, Germany.; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany. Niknejad A; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Hall C; Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 4HN, UK. Jacobs D; Nederlandse Obesitas Kliniek, Huis Ter Heide, 3712 BA Utrecht, The Netherlands. Marek D; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Fraser DP; University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK. Thuillier D; Univ Lille, Inserm, CHU Lille, Pasteur Institute Lille, U1190 Translational Research for Diabetes, European Genomic Institute of Diabetes, 59000 Lille, France. Ahmadizar F; Data Science and Biostatistics Department, Julius Global Health, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands. Mehl F; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Pattou F; Univ Lille, Inserm, CHU Lille, Pasteur Institute Lille, U1190 Translational Research for Diabetes, European Genomic Institute of Diabetes, 59000 Lille, France. Burdet F; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Hawkes G; University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK. Arts ICW; Maastricht Center for Systems Biology, Faculty of Science and Engineering, Maastricht University, Paul Henri Spaaklaan 1, 6229 EN Maastricht, The Netherlands. Blanch J; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.; ISV-Girona Research Group, Research Unit in Primary Care, Primary Care Services, Catalan Institute of Health (ICS), 08908 Barcelona, Spain. Van Soest J; Brightlands Institute for Smart Society (BISS), Faculty of Science and Engineering, Maastricht University, 6229 EN Maastricht, The Netherlands.; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Reproduction, Maastricht University Medical Center, 6229 EN Maastricht, The Netherlands. Fernández-Real JM; Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007 Girona, Spain.; Department of Medical Sciences, School of Medicine, University of Girona, 17003 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Av. França, s/n, 17007 Girona, Spain. Boehl J; Global Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach, Germany. Fink K; Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, 89081 Ulm, Germany.; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany. van Greevenbroek MMJ; Department of Internal Medicine and CARIM School of Cardiovascular Diseases, Maastricht University, 6229 EN Maastricht, The Netherlands. Kavousi M; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands. Minten M; Maastricht Center for Systems Biology, Faculty of Science and Engineering, Maastricht University, Paul Henri Spaaklaan 1, 6229 EN Maastricht, The Netherlands. Prinz N; Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, 89081 Ulm, Germany.; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany. Ipsen N; Novo Nordisk A/S, 2860 Søborg, Denmark. Franks PW; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre (CRC), Lund University, Jan Waldenströmsgata 35, SE-20502 Malmö, Sweden. Ramos R; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.; Department of Medical Sciences, School of Medicine, University of Girona, 17003 Girona, Spain.; Department of Medical Informatics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.; Research in Vascular Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Parc Hospitalari Martí i Julià, Edifici M2, 17190 Salt, Spain. Holl RW; Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, 89081 Ulm, Germany.; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany. Horban S; Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 4HN, UK. Duarte-Salles T; Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.; Department of Medical Informatics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands. Tran VDT; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Raverdy V; Univ Lille, Inserm, CHU Lille, Pasteur Institute Lille, U1190 Translational Research for Diabetes, European Genomic Institute of Diabetes, 59000 Lille, France. Leal Y; Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007 Girona, Spain.; Department of Medical Sciences, School of Medicine, University of Girona, 17003 Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Av. França, s/n, 17007 Girona, Spain. Lenart A; Novo Nordisk A/S, 2860 Søborg, Denmark. Pearson E; Division of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee DD1 4HN, UK. Sparsø T; Novo Nordisk A/S, 2860 Søborg, Denmark. Giordano GN; Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre (CRC), Lund University, Jan Waldenströmsgata 35, SE-20502 Malmö, Sweden. Ioannidis V; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland. Soh K; Novo Nordisk A/S, 2860 Søborg, Denmark. Frayling TM; University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK.; Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, 1 Rue Michel-Servet, CH-1211 Geneva, Switzerland. Le Roux CW; Diabetes Complications Research Centre, University College Dublin, D04 V1W8 Dublin, Ireland. Ibberson M; Vital-IT Group, SIB Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.
Pokaż więcej
Źródło:
Life (Basel, Switzerland) [Life (Basel)] 2024 Feb 16; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 16.
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Autorzy:
Longinetti E; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Bower H; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. McKay KA; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Englund S; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Burman J; Department of Neuroscience, Uppsala University, Uppsala, Sweden. Fink K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Fogdell-Hahn A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Gunnarsson M; Department of Neurology, Örebro University, Örebro, Sweden. Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Langer-Gould A; Clinical and Translational Neuroscience, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, USA. Lycke J; Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden. Nilsson P; Department of Clinical Sciences, Division of Neurology, Lund University, Lund, Sweden. Salzer J; Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden. Svenningsson A; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. Mellergård J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Piehl F; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Frisell T; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial.
Time of delivery among low-risk women at 37-42 weeks of gestation and risks of stillbirth and infant mortality, and long-term neurological morbidity.
Autorzy:
Razaz N; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Muraca GM; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Obstetrics and Gynaecology, BC Children's and Women's Hospital and Health Centre and the University of British Columbia, Vancouver, BC, Canada. Fink K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Centrum for Neurology, Academical Specialist Center, Stockholm, Sweden. Boutin A; Department of Obstetrics and Gynaecology, BC Children's and Women's Hospital and Health Centre and the University of British Columbia, Vancouver, BC, Canada. John S; Department of Obstetrics and Gynaecology, BC Children's and Women's Hospital and Health Centre and the University of British Columbia, Vancouver, BC, Canada. Lisonkova S; Department of Obstetrics and Gynaecology, BC Children's and Women's Hospital and Health Centre and the University of British Columbia, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. Stephansson O; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden. Cnattingius S; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Joseph KS; Department of Obstetrics and Gynaecology, BC Children's and Women's Hospital and Health Centre and the University of British Columbia, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies